Emergent BioSolutions CEO Robert Kramer's 2020 pay jumps 1,620% to $5.6M
Emergent BioSolutions reports 2020 executive compensation
By ExecPay News
Published: April 9, 2021
Emergent BioSolutions reported fiscal year 2020 executive compensation information on April 9, 2021.
In 2020, five executives at Emergent BioSolutions received on average a compensation package of $3.1M, a 30% increase compared to previous year.
Average pay of disclosed executives at Emergent BioSolutions
Robert Kramer, Chief Executive Officer, received $5.6M in total, which increased by 51% compared to 2019. 37% of Kramer's compensation, or $2.1M, was in stock awards. Kramer also received $1.2M in non-equity incentive plan, $1.4M in option awards, $894K in salary, as well as $8.7K in other compensation.
For fiscal year 2020, the median employee pay was $128,545 at Emergent BioSolutions. Therefore, the ratio of Robert Kramer's pay to the median employee pay was 43 to one.
Fuad El-Hibri, Chairman, received a compensation package of $3.2M, which increased by 7% compared to previous year. 37% of the compensation package, or $1.2M, was in stock awards.
Richard S. Lindahl, Chief Financial Officer, earned $2.3M in 2020, a 22% increase compared to previous year.
Adam Havey, Executive Vice President, Business Operations, received $2.2M in 2020, which increases by 18% compared to 2019.
Atul Saran, General Counsel, earned $2.2M in 2020, a 16% increase compared to previous year.
Related executives
Fuad El-Hibri
Emergent BioSolutions
Chairman
Robert Kramer
Emergent BioSolutions
Chief Executive Officer
Richard Lindahl
Emergent BioSolutions
Chief Financial Officer
Adam Havey
Emergent BioSolutions
Chief Operating Officer
Atul Saran
Emergent BioSolutions
Executive Vice Presidentand Chief Strategy andand Development Officer
You may also like
Source: SEC filing on April 9, 2021.